Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInforma Regulatory News (INF)

Share Price Information for Informa (INF)

Share Price is delayed by 15 minutes
Get Live Data
811.20    -2.00 (-0.25%)
Bid:
809.00
Ask:
809.40
Spread: 0.40 (0.049%)
Market Cap: £10.20b
INF Live PriceLast checked at - London Stock Exchange

Intraday Informa Share Chart

First Quarter Trading Update

1 May 2025 07:00

RNS Number : 9294G
Informa PLC
01 May 2025
 

Informa LEI: 5493006VM2LKUPSEDU20

 

Informa PLC Press Release

1 May 2025

First Quarter Trading Update

Q1...Continuing strong growth, full year guidance reaffirmed

Informa (LSE: INF.L), the international Live B2B Events, B2B Digital Services and Academic Markets Group today published an update on trading, confirming further strong growth in Q1 and continuing forward visibility through subscriptions, recurring revenues and forward booked contracts.

Stephen A. Carter, Group Chief Executive, Informa, said:

"The Informa Group continues to deliver strong underlying growth in both Live B2B Events and Academic Markets."

He added: "Specialist Brands in Specialist Markets, annual/multi-year Subscriptions, forward booked revenues, and leading positions in faster growing geographies, underpin the Informa growth platform."

Highlights

· Strong growth...Q1 total Group underlying revenue growth of 7.6%, with strong performances across the Live B2B Events portfolio and in Academic Markets. Group H1 underlying growth delivering to targeted growth ambition;

· Revenue visibility...2025 revenues of £2.5bn+ already traded, booked or committed through subscriptions, recurring exhibitor revenues and forward booked contracts, 61% of full year target revenues and pacing ahead of 2024;

· Major B2B Brands...55 of the Top 100 B2B Brands trade in H1, underpinning the full year 7%+ underlying revenue growth target across the Live B2B Events portfolio;

· Geographic Outperformance…Strong demand across all regions in Q1, continued market leading outperformance in IMEA (India, Middle East and Africa);

· Creation of Informa Festivals complete...Combination of the Informa brands and the Ascential portfolio completed on schedule, and combined Informa Festivals business performing to plan on both revenue growth and synergy delivery;

· Full Year guidance reaffirmed...Full year Group underlying revenue growth guidance of 5%+, £4.1bn± revenue target and double digit adjusted earnings growth reaffirmed. (2025 full year average FX of GBP/USD 1.27);

· Share Buybacks...2025 Share Buyback Programme ongoing, initial commitment of £200m.

 

Enquiries

Stephen A. Carter, Group Chief Executive

+44 (0) 20 8052 0400

Gareth Wright, Group Finance Director

+44 (0) 20 8052 0400

Richard Menzies-Gow, Director of IR & Communications

+44 (0) 20 8052 2787

Tim Burt / Anthony Di Natale - Teneo

+44 (0) 7583 413254 / +44 (0) 7880 715975

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAPLEDEPSEFA
Date   Source Headline
8th Jun 20267:00 amRNSTransaction in Own Shares
4th Jun 202612:14 pmRNSHolding(s) in Company
1st Jun 202610:00 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
26th May 20267:00 amRNSTransaction in Own Shares
22nd May 20262:52 pmRNSHolding(s) in Company
22nd May 20269:40 amRNSDirector/PDMR Shareholding
18th May 20267:00 amRNSTransaction in Own Shares
11th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 202610:00 amRNSTotal Voting Rights
30th Apr 20267:00 amRNSAnnual Financial Report and Notice of 2026 AGM
27th Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSAppointment of inD CEO
15th Apr 20263:30 pmRNSDirector/PDMR Shareholding
13th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 202612:01 pmRNSHolding(s) in Company
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202610:00 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSFinal Results
12th Mar 20267:00 amRNSFinal Results
9th Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20269:11 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 202612:32 pmRNSDirectorate change
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 202610:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.